|
|||||
|
|
Chicago, IL – March 11, 2026 – Stocks in this week’s article are Trevi Therapeutics, Inc. TRVI, Metalla Royalty & Streaming Ltd. MTA and Vermilion Energy Inc. VET.
As March begins, investors might consider taking a more active role in selecting stocks by watching for potential breakout opportunities within specified price ranges. Under this approach, a stock should be sold if its price falls below the lower trading band, while a move above the upper band signals an opportunity to hold onto the stock and gain from further upward momentum.
Using this method, Trevi Therapeutics, Inc., Metalla Royalty & Streaming Ltd. and Vermilion Energy Inc. stand out as potential breakout stocks in March. All three have already posted strong gains over the past year, with Trevi Therapeutics, Metalla Royalty & Streaming and Vermilion Energy up 119.1%, 222.2% and 54.5%, respectively, indicating ongoing momentum.
To pick a breakout stock, calculate support and resistance levels. A support level is the lower bound for stock movements, while a resistance level refers to the maximum price it trades at within a considerable period.
In other words, the demand for a stock is lowest at its support level, meaning most traders are willing to sell it. The majority of traders are willing to go long on the stock at the resistance level, indicating they would like to add it to their portfolios. The key to identifying breakout stocks is to zero in on those on the verge of a breakout or those that have just broken above the resistance level.
The primary risk associated with such a strategy is that the decision to buy an apparent breakout candidate has been incorrectly timed. When a stock moves above the resistance level, it should be a highly prized commodity for traders. However, whether such a breakout is genuine is another matter altogether.
For a bona fide breakout, the stock’s earlier resistance barrier should become its new support level. This only happens if the established trading channel is tested by observing long-term price trends. The strength of the support and resistance levels can be ascertained only through such a study. Despite the risk of misidentification, correctly identifying such stocks can yield considerable returns, even at a price that may not seem attractive at first glance.
These criteria narrow the universe of more than 6,853 stocks to only 7. Here are the top three stocks:
Trevi Therapeutics operates as a clinical-stage biopharmaceutical firm. It has a Zacks Rank #2. TRVI’s expected earnings growth rate for the current year is 23.4%.
Metalla Royalty & Streaming is a company focused on precious metals royalties and streaming. It has a Zacks Rank #2. MTA’s expected earnings growth rate for the current year is 100%.
Vermilion Energy explores, develops, and produces oil and natural gas across North America, Europe and Australia. It has a Zacks Rank #1. VET’s expected earnings growth rate for the current year is 268.4%.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2881146/up-over-50-3-stocks-on-the-verge-of-a-massive-breakout-in-march
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: [email protected]
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| 5 hours | |
| Mar-10 | |
| Mar-09 | |
| Mar-09 | |
| Mar-09 | |
| Mar-09 | |
| Mar-06 | |
| Mar-05 | |
| Mar-04 | |
| Mar-04 | |
| Mar-04 | |
| Mar-04 | |
| Mar-02 | |
| Feb-25 | |
| Feb-23 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about Finviz Elite